MD Anderson Cancer Center partners with biotech co. to improve cancer immunotherapy response


Dr. Jennifer Wargo, director of MD Anderson's Platform for Innovative Microbiome and Translational Research, said the partnership with Federation Bio is significant because of difficulties performing fecal transplant.

Previous FCA Venture Partners, Nashville-based health tech venture firm, closes $71 million fund
Next A downtown People's Park restaurant more than 10 years in making